Cargando…
JAK3 inhibition: what potential for the future?
JAK3 inhibition with the CP-690,550 compound has an immunosuppressive potency in murine models, nonhuman primates and humans. This drug blocks STAT5 activation in most T-cell subpopulations but less effectively in T-regulator cells. In low to moderate risk human kidney transplant recipients, combine...
Autor principal: | Legendre, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834527/ https://www.ncbi.nlm.nih.gov/pubmed/24565406 http://dx.doi.org/10.1186/2047-1440-2-S1-S6 |
Ejemplares similares
-
JAK Inhibition for the Treatment of Myelofibrosis: Limitations and Future Perspectives
por: Bose, Prithviraj, et al.
Publicado: (2020) -
Basic Mechanisms of JAK Inhibition
por: Lin, Chung MA, et al.
Publicado: (2020) -
The infection risks of JAK inhibition
por: Adas, Maryam A., et al.
Publicado: (2021) -
Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis
por: Kuykendall, Andrew T., et al.
Publicado: (2020) -
A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition
por: McInnes, Iain B, et al.
Publicado: (2021)